The making of the one pill-Developing single tablet regimens for HIV and for HCV

Yang, TY; Oliyai, R; Kent, KM

Yang, TY (通讯作者),Gilead Sci Inc, Dept Pharmaceut Dev & Mfg, Foster City, CA 94404 USA.

ANTIVIRAL THERAPY, 2022; 27 (1):

Abstract

A concept of all or nothing inspired the innovation of a one-pill-once-daily HIV treatment. Atripla (R) was the one pill that combined efavirenz, emtr......

Full Text Link